Unclassifiable ILD
Sarcoidosis
Despite extensive investigation and multidisciplinary team discussion, some patients have ILD that is considered unclassifiable, for which there are no approved treatments.
For more information on our current and past study involvement, please follow the links to the left.
Studies & trials
-
uILD Study MA39189
A phase II randomised double blind placebo controlled trial to study the efficacy of pirfenidone versus placebo in patients with unclassifiable ILD over a 24 week period. This study has completed recruitment. This study has now been published.